Haemonetics is consolidating its three reportable segments into two: combining Plasma and Blood Center into Apheresis, and renaming Hospital to MedSurg, effective Q1 fiscal 2027. The restructuring aligns external financial reporting with internal business management while maintaining supplemental revenue disclosures for investor comparability.